Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
23.71
+0.22 (0.94%)
At close: Apr 28, 2026, 4:00 PM EDT
24.18
+0.47 (1.98%)
After-hours: Apr 28, 2026, 6:32 PM EDT
Immunome Employees
Immunome had 177 employees as of December 31, 2025. The number of employees increased by 59 or 50.00% compared to the previous year.
Employees
177
Change (1Y)
59
Growth (1Y)
50.00%
Revenue / Employee
$39,215
Profits / Employee
-$1,199,966
Market Cap
2.68B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| ADMA Biologics | 647 |
| Tarsus Pharmaceuticals | 370 |
| Vera Therapeutics | 249 |
| Celldex Therapeutics | 198 |
| Soleno Therapeutics | 182 |
| Disc Medicine | 155 |
| IDEAYA Biosciences | 145 |
IMNM News
- 7 days ago - Immunome Announces Oral Presentation of Phase 3 RINGSIDE Data at 2026 ASCO Annual Meeting - Business Wire
- 14 days ago - Immunome (IMNM) Price Forecast: Breakout Points to Higher Highs Ahead - FXEmpire
- 26 days ago - Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - Immunome Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Immunome Reports Full Year 2025 Financial Results and Provides Business Update - Business Wire
- 2 months ago - Immunome Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Immunome to Present at Upcoming Investor Conferences - Business Wire
- 2 months ago - Immunome Transcript: Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Transcripts